CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-05 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 293,500 | ||
| 2023-06-30 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +7,255 | $36.75 | $267K | 26,503 |
| 2023-06-30 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,255 | $93.27 | $677K | 19,248 |
| 2023-06-30 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −7,255 | 72,545 | ||
| 2023-06-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion 10b5-1 | +3,500 | $36.75 | $129K | 43,002.69 |
| 2023-06-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −3,500 | $89.77 | $314K | 39,502.69 |
| 2023-06-14 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −3,500 | 79,500 | ||
| 2023-06-14 | Wood Larry L Global President TAVR & Surg | Exercise or conversion 10b5-1 | +8,660 | $45.28 | $392K | 222,453.71 |
| 2023-06-14 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −2,850 | $90.71 | $259K | 219,603.71 |
| 2023-06-14 | Wood Larry L Global President TAVR & Surg | Sale 10b5-1 | −5,810 | $89.87 | $522K | 213,793.71 |
| 2023-06-14 | Wood Larry L Global President TAVR & Surg | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −8,660 | 49,719 | ||
| 2023-06-13 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion 10b5-1 | +5,000 | $36.75 | $184K | 40,055.78 |
| 2023-06-13 | Szyman Catherine M. CVP, Critical Care | Sale 10b5-1 | −5,000 | $85.81 | $429K | 35,055.78 |
| 2023-06-13 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −5,000 | 67,000 | ||
| 2023-06-01 | MUSSALLEM MICHAEL A Director | Exercise or conversion 10b5-1 | +29,350 | $36.75 | $1.1M | 115,559.82 |
| 2023-06-01 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −5,300 | $83.43 | $442K | 110,259.82 |
| 2023-06-01 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −5,396 | $85.08 | $459K | 104,863.82 |
| 2023-06-01 | MUSSALLEM MICHAEL A Director | Sale 10b5-1 | −18,654 | $84.57 | $1.6M | 86,209.82 |
| 2023-06-01 | MUSSALLEM MICHAEL A Director | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,350 | 322,850 | ||
| 2023-05-24 | Wood Larry L Global President TAVR & Surg | Exercise or conversion 10b5-1 | +6,421 | $45.28 | $291K | 220,214.71 |
Page 37 of 43 · 841 trades